Zoetis has introduced Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early, robust protection against Marek’s disease (MD), infectious bursal disease (IBD), and Newcastle disease (ND) viruses with one dose.
Dr Sing Rong, Zoetis Research Director, said the new vaccine is ...
Sign in as a member, or Join our Community for free to unlock the full article.
Zoetis has introduced Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early, robust protection against Marek’s disease (MD), infectious bursal disease (IBD), and Newcastle disease (ND) viruses with one dose.
Dr Sing Rong, Zoetis Research Director, said the new vaccine is ...
Sign in as a member, or Join our Community for free to unlock the full article.
Zoetis has introduced Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early, robust protection against Marek’s disease (MD), infectious bursal disease (IBD), and Newcastle disease (ND) viruses with one dose.
Dr Sing Rong, Zoetis Research Director, said the new vaccine is ...
Sign in as a member, or Join our Community for free to unlock the full article.
Zoetis has introduced Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early, robust protection against Marek’s disease (MD), infectious bursal disease (IBD), and Newcastle disease (ND) viruses with one dose.
Dr Sing Rong, Zoetis Research Director, said the new vaccine is ...
Sign in as a member, or Join our Community for free to unlock the full article.
Zoetis has introduced Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early, robust protection against Marek’s disease (MD), infectious bursal disease (IBD), and Newcastle disease (ND) viruses with one dose.
Dr Sing Rong, Zoetis Research Director, said the new vaccine is ...
Sign in as a member, or Join our Community for free to unlock the full article.
Zoetis has introduced Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early, robust protection against Marek’s disease (MD), infectious bursal disease (IBD), and Newcastle disease (ND) viruses with one dose.
Dr Sing Rong, Zoetis Research Director, said the new vaccine is ...
Sign in as a member, or Join our Community for free to unlock the full article.
Zoetis has introduced Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early, robust protection against Marek’s disease (MD), infectious bursal disease (IBD), and Newcastle disease (ND) viruses with one dose.
Dr Sing Rong, Zoetis Research Director, said the new vaccine is ...
Sign in as a member, or Join our Community for free to unlock the full article.
Zoetis has introduced Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early, robust protection against Marek’s disease (MD), infectious bursal disease (IBD), and Newcastle disease (ND) viruses with one dose.
Dr Sing Rong, Zoetis Research Director, said the new vaccine is ...
Sign in as a member, or Join our Community for free to unlock the full article.
Zoetis has introduced Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early, robust protection against Marek’s disease (MD), infectious bursal disease (IBD), and Newcastle disease (ND) viruses with one dose.
Dr Sing Rong, Zoetis Research Director, said the new vaccine is ...
Sign in as a member, or Join our Community for free to unlock the full article.
Zoetis has introduced Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early, robust protection against Marek’s disease (MD), infectious bursal disease (IBD), and Newcastle disease (ND) viruses with one dose.
Dr Sing Rong, Zoetis Research Director, said the new vaccine is ...
Sign in as a member, or Join our Community for free to unlock the full article.
Zoetis has introduced Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early, robust protection against Marek’s disease (MD), infectious bursal disease (IBD), and Newcastle disease (ND) viruses with one dose.
Dr Sing Rong, Zoetis Research Director, said the new vaccine is ...
Sign in as a member, or Join our Community for free to unlock the full article.
Zoetis has introduced Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early, robust protection against Marek’s disease (MD), infectious bursal disease (IBD), and Newcastle disease (ND) viruses with one dose.
Dr Sing Rong, Zoetis Research Director, said the new vaccine is ...
Sign in as a member, or Join our Community for free to unlock the full article.
Zoetis has introduced Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early, robust protection against Marek’s disease (MD), infectious bursal disease (IBD), and Newcastle disease (ND) viruses with one dose.
Dr Sing Rong, Zoetis Research Director, said the new vaccine is ...
Sign in as a member, or Join our Community for free to unlock the full article.
Zoetis has introduced Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early, robust protection against Marek’s disease (MD), infectious bursal disease (IBD), and Newcastle disease (ND) viruses with one dose.
Dr Sing Rong, Zoetis Research Director, said the new vaccine is ...
Sign in as a member, or Join our Community for free to unlock the full article.
Zoetis has introduced Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early, robust protection against Marek’s disease (MD), infectious bursal disease (IBD), and Newcastle disease (ND) viruses with one dose.
Dr Sing Rong, Zoetis Research Director, said the new vaccine is ...
Sign in as a member, or Join our Community for free to unlock the full article.
Zoetis has introduced Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early, robust protection against Marek’s disease (MD), infectious bursal disease (IBD), and Newcastle disease (ND) viruses with one dose.
Dr Sing Rong, Zoetis Research Director, said the new vaccine is ...
Sign in as a member, or Join our Community for free to unlock the full article.
Zoetis has introduced Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine that provides early, robust protection against Marek’s disease (MD), infectious bursal disease (IBD), and Newcastle disease (ND) viruses with one dose.
Dr Sing Rong, Zoetis Research Director, said the new vaccine is ...
Sign in as a member, or Join our Community for free to unlock the full article.
ASIAN AGRIBUSINESS MEDIA PTE LTD
Would you like to join your colleagues in the Asian Agribiz Community. Click here to JOIN NOW!
